Biography
- Division Head, Developmental and Behavioral Pediatrics, Ann & Robert H. Lurie Children’s Hospital of Chicago
- Irene Heinz Given and John La Porte Given Research Professorship in Pediatrics, Ann & Robert H. Lurie Children’s Hospital of Chicago
See Lurie Children's Provider Profile
Joshua Ewen, MD, is a pediatric neurologist, neurodevelopmental specialist, and clinical neurophysiologist. He serves as Division Head of Developmental-Behavioral Pediatrics. His research has been focused primarily on the borderlands between sensory-motor function and cognition in autism and ADHD, but his is lab is also interested in theory-based data integration in psychology and in biomarker validation methodology.
Education and Background
- Fellowship in clinical neurophysiology, Johns Hopkins Hospital 2006–2007
- Residency in neurodevelopmental disabilities, Johns Hopkins Hospital 2002–2006
- Residency in pediatrics, Cincinnati Children’s Hospital Medical Center 2000–2002
- MD, Tulane University School of Medicine 2000
Research Highlights
CAUSAL ANALYSIS OF EVIDENCE FOR THEORIES OF AUTISM
Science consists of many different studies, yet we need to integrate information together to really understand answers to complex questions, like which features of autism cause other features of autism. We employ large data sources, formalization of psychological theories as graphs and causal-inference statistical analysis to evaluate evidence for a variety of theories of autism.
REPETITIVE TMS TREATMENTS FOR ADHD
This work builds on decades of research understanding the neurobiology of ADHD. It involves novel approaches to targeting repetitive TMS brain stimulation to mitigate the symptoms of ADHD.
REPORTING GUIDELINES FOR EEG-BASED BIOMARKER VALIDATION STUDIES
Biomarkers based on EEG are expected to help diagnosis and monitoring in developmental, psychiatric,
and other neurological conditions. A group of experts convened under IFCN is identifying the important
elements of information needed to prove rigorously that these biomarkers perform as intended and can
be relied upon in clinical care and in clinical trials.
Featured Grants
ADHD PreSMART: ADHD PreSMA Response inhibition Therapy
National Institutes of Health/National Institute of Mental Health
